FDA Inspection
PLZ CorpPLZ Corp – FDA Inspection, Apr 3, 2019
Record Details
This FDA Inspection record concerns PLZ Corp, with an inspection on April 3, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 9f6da7f3-d7f3-4050-953e-e11302f69a62
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1085270
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.58Buildings not maintained in good state of repair
- 21 CFR 211.84(d)(2)Reports of Analysis (Components)
- 21 CFR 211.67(b)Written procedures not established/followed
- 21 CFR 211.192No written record of investigation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of PLZ Corp
3| Date | Classification | Office | Project area |
|---|---|---|---|
| January 15, 2025 | VAI | New England District Office | Drug Quality Assurance |
| April 24, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 26, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for PLZ Corp
- FDA Inspection 1254542 - 2025-01-15
- FDA Inspection 874347 - 2014-04-24
- FDA Inspection 736706 - 2011-07-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.